Bibliografia Acotada

1. DEMEESTER STEVEN, DEMEESTER TOM. Columnar mucosa and intestinal metaplasia of the esophagus. Fifty years of controversy. Ann Surg 2000; 231: 303-321.
2. BARRETT M. The lower esophagus lined by columnar epithelium. Surgery 1957; 41: 881-894.
3. PAULL A, TRIER JS, DALTON MD, CAMP RC, LOEB P, GOYAL RK. The histologic spectrum of Barrett esophagus. N Eng J Med 1976; 295: 476-480.
4. SAMPLINER RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 1028-1032.
5. PHILLIPS RW, WONG RK. Barrett´s esophagus. Natural history, incidence, etiology, and complications (review). Gastroenterol Clin North Am 1991; 20: 791-816.
6. CAMERON AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma (review). Gastroenterol Clin North Am 1997; 26: 487-494.
7. MELGUIZO BERMÚDEZ M. Esófago de Barrett y cirugía antirreflujo. Rev Colomb Cir 2001: 16: 180-184.
8. CAMERON AJ, ZINSMEISTER AR, BALLARD DJ, et al. Prevalence of columnar –lined (Barrett´s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918-922.
9. BREMNER CG, BREMNER RM. Barrett´s esophagus. 1997; 77: 115-1137.
10. CAMERON AJ, OTT BJ, PAYNE WS. The incidence of adenocarcinoma in columnar-lined (Barrett´s) esophagus. N Engl J Med 1985; 313: 857-859.
11. REID BJ. Barrett´s Esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 1991; 20: 817-833.
12. PATIÑO JF. Esófago de Barrett. Rev Colomb Cir 2002; 17: 37-65.
13. STEIN HJ, KAUER WKH, FEUSSNER H, et al. Bile reflux in benign and malignant Barrett’s esophagus: effect of medical acid suppression and Nissen fundoplication. J Gastrointest Surg 1998; 2: 333-341.
14. ORTIZ A, MARTÍNEZ DE HARO LF, PARRILLA P, et al. Conservative treatment versus antireflux surgery in Barrett´s esophagus: longterm results of a prospective study. Br J Surg 1996; 83: 274-278.
6. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar –lined (Barrett´s) esophagus. Comparison of populationbased clinical and autopsy findings. Gastroenterology 1990; 99: 918-922.
15. SPECHLER SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 1992; 326: 786-792.
16. HORGAN S, PELLEGRINI CA. Surgical treatment of gastroesophageal reflux disease. Surg Clin North Am 1997; 77: 1063-1087.
17. HUNTER JG, TRUS TL, BRANUM GD, et al. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996; 223: 673-687.
18. RICHARDSON WS, TRUS TL, HUNTER JG. Laparoscopic antireflux surgery. Surg Clin North Am 1996; 76: 437-450.
19. MELGUIZO M. Cirugía antirreflujo por laparoscopia. Una serie de 100 pacientes. Rev Colomb Cir 2001; 16: 72-80.
20. ZUNDEL N, RESTREPO H, VÁSQUEZ J, TORO R. Cirugía antirreflujo por laparoscopia. Rev Colomb Cir 1997; 12: 267-271.
21. URIBE AL, MORALES CH, RAMÍREZ N, VALENCIA JT. Tratamiento laparoscópico de la enfermedad por reflujo gastroesofágico. Rev Colomb Cir 1999; 14: 224-230.
22. ARANGO LA, ÁNGEL P. Reflujo gastroesofágico. Conceptos actuales, evaluación y presentación de 50 enfermos intervenidos laparoscópicamente con seguimiento de 6 meses. Rev Colomb Cir 1997; 12: 251-263.
23. WETSCHER GJ, GLASER K, WIESCHEMEYER T, et al. Cisapride enhances the effect of partial posterior fundoplication on esophageal peristalsis in GERD patients with poor esophageal contractility. Dig Dis Sci 1998; 43: 1986-1990.
24. HINDER RA, FILIPI CJ, WETSCHER G, et al. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994; 220: 472-483.
25. DEMEESTER SR. History of Barrett’s esophagus and definition of terms. Prob Gen Surg 2001; 18: 1-3.
26. JAMIESON GG, FRANCE M, WATSON DI. Results of laparoscopic antireflux operations in patients who have Barrett’s esophagus. Chest Surg Clin North Am 2002; 12: 149-155.
27. PARRILLA P, MARTÍNEZ DE HARO LF, ORTIZ A, MUNITIZ V. Standard antireflux operations in patients who have Barrett’s esophagus. Current results. Chest Surg Clin N Am 2002; 12: 113-126.
28. DEMEESTER SR, PETERS JH, DEMEESTER TR. Barrett’s esophagus. Curr Probl Surg 2001; 38: 553.
29. MCCALLUM R, POLEPALLE S, DAVENPORT K, FRIERSON H, BOYD S. Role of antireflux surgery against dysplasia in Barrett’s esophagus. Gastroenterology 1991; 100: A12.
30. KATZ D, ROTHSTEIN R, SCHNED A, DUNN J, SEAVER K, ANTONIOLI D. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett’s esophagus. Am J Gastroenterol 1998; 93: 536-541.
31. HOFSTETTER W, PETERS J, DEMEESTER TM, HAGEN JA, DEMEESTER SR, et al. Long-Term outcome of antireflux surgery in patients with barrett’s esophagus. Ann Surg 2001; 234: 532-539.
32. WETSCHER GJ, GADENSTAETTER M, KLINGER PJ, et al. Efficacy of medical therapy and antireflux surgery to prevent Barrett’s metaplasia in patients with gastroesophageal reflux disease. Ann Surg 2001; 234: 627-632.
33. WETSCHER GJ, GLASER K, GADENSTAETTER M, et al. The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease (GERD) without esophageal stricture. Am J Surg 1999; 177: 189-192.
34. HINDER RA, STEIN HJ, BREMNER CG, et al. Relationship of a satisfactory outcome to normalization of delayed gastric empting after Nissen fundoplication. Ann Surg 1989; 210: 458-465.
35. FARRELL TM, ARCHER SB, GALLOWAY KD, et al. Heatburn is more likely to recur after Toupet fundoplication than Nissen fundoplication. Ann Surg 2000; 66: 229-237.
36. JOBE B, WALLACE J, HANSEN P, SWANSTROM L. Evaluation of laparoscopic Toupet fundoplication as a primary repair for all patients with medically resistant gastroesophageal reflux. Surg Endosc 1997; 11: 1089-1093.
37. TYTGAT GNJ. Endoscopic features of the columnar-lined esophagus. Gastroenterol Clin North Am 1997; 26: 507-517.
38. PROVENZALE D, KEMP JA, ARORA S, WONG JB. A guide for surveillance of patients with Barrett´s esophagus. Am J Gastroenterol 1994; 89: 670-680.
39. BOSCHER L, TAYLOR F. Heterotopic gastric mucosa in the esophagus with ulceration and stricture formation. J Thorac Cardiovasc Surg 1951; 21: 306-312.
40. JASS JR. Mucin histochemistry of the columnar epithelium of the esophagus: a retrospective study. J Clin Pathol 1981; 34: 866-870.
41. TORRADO J, CORREA P, RUIZ B, BERNARDI P, ZAVALA D, BARA J. Lewis antigen alterations in gastric cancer precursors. Gastroenterology 1992; 102: 424-430.
42. TORRADO J, CORREA P, RUIZ B, BERNARDI P, ZAVALA D, BARA J. Lewis antigen alterations in gastric cancer precursors. Gastroenterology 1992; 102: 424-30.
43. LEVINE D, HAGGITT R, IRVINE S, REID B. Natural history of highgrade dysplasia in Barrett’s esophagus. Gastroenterology 1996; 110: A550.
44. SCHNELL T, SONTAG S, CHEJFEC G, et al. High-grade dysplasia (HGD) is not an indication for surgery in patients with Barrett’s esophagus. Gastroenterology 1996; 110: A590.
45. PETERS JH, CLARK GW, IRELAND AP, CHANDRASOMA P, SMYRK TC, DEMEESTER TR. Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108: 813-822.
46. FERGUSON MK, NAUNHEIM KS. Resection for Barrett’s mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 1997; 114:824-829.
47. CAMERON AJ, CARPENTER HA. Barrett’s esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997; 92: 586-591.
48. NIGRO JJ, HAGEN JA, DEMEESTER TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999; 117: 16-25.
49. GARCÍA A, VINAGRERAS J. TACATIC B. Terapia de ablación en pacientes con esófago de Barrett utilizando electrocoagulación con argón plasma: experiencia preliminar en el Hospital Español de México. Endoscopia 1999; 10: 151-154.
50. BREMNER RM, BREMNER CG. Ablation therapy for Barrett’s esophagus. Prob Gen Surg 2001; 18: 85-93.
51. OVERHOLT BF, PANJEHPOUR M, HAYDECK JM. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endosc 1999; 49: 1-7.
52. BREMNER RM, MASON RJ, BREMNER CG et al. Ultrasonic intraluminal ablation of esophageal mucosa: a new technique for Barrett´s ablation. Surg Endosc 1998; 12: 342-347.
53. HAGEN JA. Treatment of Barrett’s with dysplasia: low grade and high grade. Prob Gen Surg 2001; 18: 99-107.
54. REY M. Aplicación de nuevos abordajes en el tratamiento de lesiones malignas y premalignas en esófago, estómago, colon y recto. Rev Colomb Cir 2001; 16: 127-136.
55. NIGRO JJ, HAGEN JA, DEMEESTER TR, et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999; 230: 433-440.
56. DE PAULA AL, HASHIBA K, FERREIRA EB, et al. Laparoscopic transhiatal esophagectomy. Surg Lap Endosc 1995; 5: 1-5.
57. COLLARD JM. High-grade dysplasia in Barrett’s esophagus. Chest Surg Clin N Am 2002; 12: 77-92.
58. REID BJ, HAGGIST RC, RUBIN CE, et al. Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum Pathol 1988; 19: 166-178.
59. SKACEL M, PETRAS RE, GRAMLICH TL, SIGEL JE, RICHTER JE, GOLDBLUM JR. The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol 2000; 95: 3383-3387.
60. MONTGOMERY E, BRONNER MP, GOLDBLUM JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett’s esophagus: a reaffirmation. Hum Pathol 2001; 32: 368-378.
61. SPECHLER SJ. Barrett’s esophagus. N Eng J Med 2002; 346: 836-842.
62. DEMEESTER SR, CAMPOS GM, DEMEESTER TR, et al. The impact of an antireflux procedure on intestinal metaplasia of the cardia. Ann Surg 1998; 228: 547-556.
63. LOW DE, LEVINE DS, DAIL DH, KOSAREK RA. Histological and anatomic changes in Barrett’s esophagus after antireflux surgery. Am J Gastroenterol 1999; 94: 80-85.

Bibliografía Consultada

1. Beck IT, Champion MC, Lemire S, Thomson AB, et al. The second canadian consensus conference on the management of patients with gastroesophageal reflux disease. Can J Gastroenterol 1997; 11 (Suppl B) :7B-20B.
2. Bremner CG, Bremner RM. Barrett's esophagus. Surg Clin North Am 1997; 77:1115-37.
3. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997; 26:487-94.
4. Csendes A, Braghetto I, Burdiles P, Diaz JC, Maluenda F, Korn O. A new physiologic approach for the surgical treatment of patients with Barrett's esophagus: technical considerations and results in 65 patients. Ann Surg 1997; 226:123-33.
5. Marshall RE, Anggiansah A, Owen WJ. Bile in the oesophagus: clinical relevance and ambulatory detection. Br J Surg 1997; 84: 21-8.
6. Richter JE. Long-term management of gastroesophageal reflux disease and its complications. Am J Gastroenterol 1997; 92: 30S-34S y 34S-35S.
7. Sampliner RE. Ablative therapies for the columnar-lined esophagus. Gastroenterol Clin North Am 1997; 26:685-94.
8. Spechler SJ. Short and ultrashort Barrett's esophagus--what does it mean? Semin Gastrointest Dis 1997; 8: 59-67.
9. Vaezi MF, Richter JE. Bile reflux in columnar-lined esophagus. Gastroenterol Clin North Am 1997; 26:565-82

Autores:

Roberto Díaz Ríos. Alumo Ayudante de cirugía
Deborah Rodríguez Verdecie. Alum. Ayudante de Med Int.

Tutor:

Dr. Orlando Lemus. Profesor de Cirugía General